Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

5 of 5 completed trials have results

Key Signals

5 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05936996Completed

Prospective Clinical Registry Evaluating Contemporary MANTA Outcomes

Role: lead

NCT05142566Not ApplicableTerminated

MANTA Ultrasound Closure Study

Role: lead

NCT03330002Completed

MANTA Registry for Vascular Large-bore Closure

Role: lead

NCT02908880Not ApplicableCompleted

MANTA Percutaneous Vascular Closure Device - The SAFE MANTA Study

Role: lead

NCT02521948Not ApplicableCompleted

Clinical Study to Evaluate the Safety and Performance of MANTA Vascular Closure Device

Role: lead

NCT02406612Not ApplicableCompleted

X-Seal EU Post-Market Clinical Follow-Up Protocol

Role: lead

All 6 trials loaded